VEGFA and neoplasm: However, a recent clinical study (Linderholm et al, 2000) provided evidence that also the intratumoral VEGF content could predict outcome following adjuvant endocrine treatment: patients with ER+ tumours, but a high VEGF expression, had a significantly shorter RFS and overall survival.